Oak Bay Biosciences

Developing the first therapy for Stargardt disease - genetic blindness
Health & Wellness
Social Impact Driven

Share

Info

$503,724 completed
$10,550 processing
of $1,000,000 CAD
50%
53
days left: closing December 10, 2021
20
investors
*No closing minimum
$250
minimum investment